GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Convertible Debt (2013 - 2020)

Updated

GT Biopharma (GTBP) recorded Convertible Debt of $26.3 million in Q4 2020.

Analysis

GT Biopharma (GTBP) Convertible Debt (2013 - 2020) Analysis & Trends

Starting with Q4 2013, GT Biopharma's Convertible Debt history includes 13 quarters.

  • Annual Convertible Debt has a five-year compound annual growth rate of 19.1% (FY2015 to FY2020).
  • Across earlier years, Convertible Debt came in at $11.14 million in FY2016 (+1.6%).
  • The Q4 2020 figure is the highest quarterly Convertible Debt in data going back to Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 GT Biopharma 6.65 Mn -16.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 26.30 Mn
Jun 30, 2017 10.88 Mn
Mar 31, 2017 10.74 Mn
Dec 31, 2016 11.14 Mn
Sep 30, 2016 400,000.00
Jun 30, 2016 528,000.00
Mar 31, 2016 553,000.00
Dec 31, 2015 10.97 Mn
Sep 30, 2015 2.29 Mn
Dec 31, 2014 634,000.00
Sep 30, 2014 306,000.00
Jun 30, 2014 156,000.00
Mar 31, 2014 128,000.00
Dec 31, 2013 97,000.00
API Access

GT Biopharma Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=GTBP&period=max&api_key=YOUR_API_KEY